TCL Archive Fredrickson, Upton Kill Plan To Convert FCRC To NIH Satellite, Will Continue L-B Contract February 9, 1979
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: New RFA, Program Announcements Coming Up Soon From BCDB for Radiation, Breast Cancer Studies December 7, 1979
TCL Archive FY2000 Appropriations: NIH Gets $17.9 Billion, A 15% Increase, In Final Budget Agreement; $3 billion to Be Delayed November 26, 1999
TCL Archive NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants February 14, 1992
